Another in vivo study using the NAFLD-HFD mouse model exhibited similar results, where AST, ALP, leptin, cholesterol, triglyceride, TNF-α, and TGF-β levels were significantly increased [84]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.